A patient with acute hypoxemic respiratory failure and diffuse alveolar hemorrhage syndrome by Bellanti, Maria Teresa et al.
APMB - Atti della Accademia Peloritana dei Pericolanti 
Classe di Scienze Medico Biologiche 
Vol. 107(2) 2019 
 
ISSN 1828-6550 
 
 
DOI: 10.6092 / 1828-6550 / APMB.107.2.2019.CCS1 
 
APMB - Atti della Accademia Peloritana dei Pericolanti - Classe di Scienze Medico-Biologiche (2019), 107(2):SS1(1-4) 
DOI: 10.6092 / 1828-6550 / APMB.107.2.2019.CCS1. 
  
  
Original Study  CCS1(1-4) 
 
A patient with acute hypoxemic respiratory failure and 
diffuse alveolar hemorrhage syndrome  
1
Maria Teresa Bellanti, 
1
Irene Coppolino, 
1
Alfio Proietto, 
1
Stefano Picciolo 
1
Rosalba Relo, 
1
Giacomo Chillè, Ignazio 
2
Salamone, 
2
Paolo Ruggeri, Gaetano 
1
Caramori 
1
 
 
1
Unità Operativa Complessa di Pneumologia Dipartimento di Scienze Biomediche Odontoiatriche e 
delle Immagini Morfologiche e Funzionali (BIOMORF) Azienda Ospedaliera Universitaria 
Policlinico “G.Martino”, Messina, Italy;2Unità Operativa Complessa di Diagnostica per Immagini, 
Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali 
(BIOMORF), Azienda Ospedaliera Universitaria Policlinico “G.Martino”, Messina, Italy.  
 
Abstract  
Case report 
We report here the case of a 32-year-old male who went to the Emergency Ward of the Sant’Agata of 
Militello Hospital (in the province of Messina, Italy) for the presence in the last 5 days of exertion dyspnea 
and hemoptysis. An arterial blood gas analysis performed in oxygen therapy [fractional concentration of 
oxygen (O2) in inspired gas % (FiO2) unknown] showed the presence of acute hypoxemic respiratory 
failure. An x-ray and computed tomography (CT) of the chest (without intravenous contrast) showed the 
presence of diffuse and bilateral pulmonary opacities with a ground glass appearance. The patient was 
transferred to our Pulmonology Clinic. His past medical history was unremarkable. Laboratory tests 
showed neutrophilia, microcytic hypochromic anemia and a slight increase of the serum C reactive protein 
level.During his hospital stay we performed a careful differential diagnostic approach to diffuse alveolar 
hemorrhage syndrome without being able to identify a cause. The lung function tests showed the presence 
of normal lung volumes and an increase of the diffusing capacity for carbon monoxide. The patient was 
treated with oxygen therapy, antibiotics, systemic glucocorticoids and red blood cells transfusions and 
discharged at home with resolution of the clinical, functional and radiological features. 
Conclusions  
We discuss here an unusual cause of acute hypoxemic respiratory failure secondary to idiopathic diffuse 
alveolar hemorrhage syndrome. 
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Introduction 
Diffuse alveolar hemorrhage (DAH) syndrome, is a rare acute, life-threatening event with 
multiple potential causes (table 1), characterized by hemoptysis, dyspnea, diffuse and bilateral 
centrilobular pulmonary opacities, acute hypoxemic respiratory failure and anemia (1,2,3,4)  
APMB - Atti della Accademia Peloritana dei Pericolanti 
Classe di Scienze Medico Biologiche 
Vol. 107(2) 2019 
 
ISSN 1828-6550 
 
 
DOI: 10.6092 / 1828-6550 / APMB.107.2.2019.CCS1 
 
APMB - Atti della Accademia Peloritana dei Pericolanti - Classe di Scienze Medico-Biologiche (2019), 107(2):SS1(1-4) 
DOI: 10.6092 / 1828-6550 / APMB.107.2.2019.CCS1. 
Case presentation 
A 32 year-old male (175 cm, 90 Kg, body mass index 29 Kg/m2), current smoker of 10 pack-
years, heavy chronic alcohol consumer [>14 drinks/week (5)], Caucasian, beekeeper, presented at 
the Emergency Ward of the Sant’Agata of Militello Hospital (in the province of Messina, Italy) 
for the onset in the last 5 days of exertion dyspnea and hemoptysis. An arterial blood gas analysis 
performed at the emergency ward performed during oxygen therapy [fractional concentration of 
oxygen (O2) in inspired gas % (FiO2) unknown] showed the presence acute hypoxemic 
respiratory failure [pH 7.47, arterial partial pressure of oxygen (PaO2) 71 mmHg, arterial partial 
pressure carbon dioxide (PaCO2) 33 mmHg]. An x-ray and computed tomography (CT) of the 
chest (without intravenous contrast) performed at the Emergency Ward showed diffuse and 
bilateral pulmonary opacities with a ground glass appearance (Figure 1 A and B). 
 
Figure 1. Chest x-ray (performed on supine position) (A) and computed tomography (CT) scan of the chest (B) performed at the 
admission of the patient to the Emergency Ward of the Sant’Agata of Militello Hospital (in the province of Messina, Italy) showing the 
presence of diffuse and bilateral pulmonary opacities with a ground glass appearance. An high resolution CT (HRCT) scan of the chest 
performed 5 days after the hospital admission to our Pulmonology Clinic, showed diffuse and bilateral centrilobular pulmonary opacities 
sparing the subpleural regions, suggesting the presence of diffuse alveolar hemorrhage (C). HRCT of the chestperformed one month after 
hospital discharge, showed a significant improvement of the radiological lesions(D). 
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Table 1. Most common causes of diffuse alveolar haemorrhage syndromereported in the literature 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
obtained with the data from the references 2,3,4,5 and www.pneumotox.com) 
Pulmonary capillaritis: Granulomatosis with polyangiitis (formerly termed Wegener's 
granulomatosis),eosinophilic granulomatous with polyangiitis 
(formerly Churg–Strauss syndrome),  microscopic polyangiitis 
(MPA), Goodpasture syndrome, isolated pauci-immune pulmonary 
capillaritis,idiopathic pulmonary hemosiderosis, Behçet syndrome, 
connective tissue disease (systemic lupus erythematosus, rheumatoid 
arthritis, mixed connective tissue disease),antiphospholipid antibody 
syndrome, cryoglobulinemia, thrombotic thrombocytopenic purpura, 
idiopathic thrombocytopenic purpura,Henoch-Schönlein purpura, 
urticaria-vasculitis syndrome, immunoglobulin A nephropathy, 
pauci-immune glomerulonephritis 
Infections Viral [influenza A (H1N1), adenovirus, human immunodeficiency 
virus (HIV), cytomegalovirus, herpes simplex virus, hantavirus, 
dengue virus], bacterial (staphyloccus aureus, leptospirosis, 
legionellosis, mycobacterium  tuberculosis), fungal (invasive 
aspergillosis), parasitic (strongyloides stercoralis, plasmodium 
falciparum, dirofilaria immitis) 
Drugs (most common reports): amiodarone, abciximab, alemtuzumab, all-transretinoic acid, arsenic 
trioxide, bevacizumab, clomifen, diphenylhydantoin, D-
penicillamine, erlotinib, irinotecan, isocyanates, methotrexate, 
mitomycin, montelukast, nitrofurantoin, propylthiouracil, sirolimus,  
sildenafil, ticlopidine 
Drugs of abuse: Crack cocaine,  cannabis 
Toxic substances: trimellitic anhydride, pesticides, glue 
Other causes: pulmonary fat embolism, high-altitude pulmonary edema, 
barotraumas, disseminated intravascular coagulation, congestive 
heart failure, malignant neoplasms (pulmonary angiosarcoma, Kaposi 
sarcoma, multiple myeloma, acute promyelocytic leukemia, uterine 
leiomyosarcoma, small cell lung cancer),pulmonary capillary 
hemangiomatosis, lymphangioleiomyomatosis, tuberous sclerosis, 
lymphangiography, acute lung-graft rejection 
Idiopathic: Idiopathic diffuse alveolar hemorrhage syndrome 
Discussion 
Diffuse alveolar hemorrhage (DAH) syndrome is a diagnostic challenge with multiple potential 
causes (table 1) that may require a careful and extensive differential diagnosis. The diagnostic 
evaluation in DAH syndrome in some patients may include fiberoptic bronchoscopy with 
bronchoalveolar lavage (BAL) to exclude airway sources of bleeding (6).  In our case fiberoptic 
bronchoscopy was not performed due to presence of severe acute hypoxemic respiratory failure. An 
increase of DLCO (due to the increase binding of carbon monoxide to intra-alveolar hemoglobin) 
suggests the diagnosis of DAH (7). Idiopathic DAH syndrome is a rare condition with more than 500 
cases of idiopathic DAH published in the literature and these patients have usually a good prognosis 
(1). There is no evidence in the scientific literature of cases of DAH syndrome caused by beech wood 
pellets fumes 
Conclusion 
We describe here an unusual case of a 32-year-old man with idiopathic diffuse alveolar hemorrhage 
(DAH) syndrome who presented with dyspnea, acute hypoxemic respiratory failure, anemia, diffuse 
and bilateral pulmonary opacities. Idiopathic DAH is  rare but usually associated a good prognosis. 
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